tiprankstipranks

Murray Stewart Insider Profile

4 Followers
Murray Stewart, CMO at Rhythm Pharmaceuticals, holds ― shares in Rhythm Pharmaceuticals (Ticker: RYTM), holds 191.50K shares in X4 Pharmaceuticals (Ticker: XFOR), holds ― shares in Amarin (Ticker: AMRN). Most recently, Murray Stewart ― shares of Rhythm Pharmaceuticals on ― for an estimated value of ―.
tipranks
Murray Stewart

Murray Stewart
Rhythm Pharmaceuticals (RYTM)
CMO

Not Ranked
Murray Stewart has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$113K
100.00%
0.00%
0.00%
A breakdown of Murray Stewart's holdings

Insider Roles

X4 Pharmaceuticals
(XFOR)
Director
Rhythm Pharmaceuticals
(RYTM)
CMO
Amarin
(AMRN)
Director
Roles that Murray Stewart holds in companies

Most Profitable Insider Trade

Stock:
X4 Pharmaceuticals
(XFOR)
Rating:Informative Sell
Date:Aug 11, 2023 - Today
Return:+54.60%
The most profitable trade made by Murray Stewart

Murray Stewart's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Rhythm Pharmaceuticals
CMO
X4 Pharmaceuticals
Jun 11, 2024
Director
Uninformative Buy
$112.80K
Amarin
Director
List of latest transactions for each holding click on a transaction to see Murray Stewart's performance on stock

Murray Stewart insider profile FAQ

What is the percentage of profitable transactions made by Murray Stewart?
The percentage of profitable transactions made by Murray Stewart is ―.
    What is the average return per transaction made by Murray Stewart?
    The average return per transaction made by Murray Stewart is ―.
      What stocks does Murray Stewart hold?
      Murray Stewart holds: RYTM, XFOR, AMRN stocks.
        What was Murray Stewart’s latest transaction?
        Murray Stewart latest transaction was an Uninformative Buy of ―.
          What was Murray Stewart's most profitable transaction?
          Murray Stewart’s most profitable transaction was an Informative Sell of XFOR stock on August 11, 2023. The return on the trade was 54.60%.
            What is Murray Stewart's role in Rhythm Pharmaceuticals?
            Murray Stewart's role in Rhythm Pharmaceuticals is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.